Suchergebnisse - "Eefting, M"

PubPharm (9)

1

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination

enthalten in: Thrombosis research | 2022

von Langerak, T. | Bakker, G. | Porcelijn, L. | +3

2

Invasive fungal infections in patients treated with Bruton's tyrosine kinase inhibitors

enthalten in: The Netherlands journal of medicine | 2020

von Dunbar, A. | Joosse, M. | de Boer, F. | +2

3

Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation

enthalten in: Bone marrow transplantation | 2019

von van der Heiden, P. | Arbous, M. | van Beers, E. | +30

4

CMV seronegative donors : Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity

enthalten in: Transplant immunology | 2018

von van der Heiden, P. | van Egmond, H. | Veld, S. | +7

5

Donor T-cell responses and disease progression patterns of multiple myeloma

enthalten in: Bone marrow transplantation | 2017

von Eefting, M. | de Wreede, L. | Von dem Borne, P. | +7

6

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL

enthalten in: Bone marrow transplantation | 2014

von Eefting, M. | Halkes, C. | de Wreede, L. | +7

ErratumIn: Bone Marrow Transplant. 2014 Feb;49(2):320

7

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL

enthalten in: Bone marrow transplantation | 2014

von Eefting, M. | Halkes, C. | de Wreede, L. | +7

8

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL

enthalten in: Bone marrow transplantation | 2014

von Eefting, M. | Halkes, C. | de Wreede, L. | +7

9

190 Efficacy of azacitidine and predictive factors for response in MDS and AML patients in the Dutch compassionate patient named programme

enthalten in: Leukemia research | 2011

von van der Helm, L. | Alhan, C. | Wijermans, P. | +20

1
[1]